| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/05/1999 | US5856360 Pharmaceutical method for the treatment of severe blood loss and for the inhibition or treatment of hemorrhagic shock |
| 01/05/1999 | US5856359 Thyroxine/cyclodextrin complexes and pharmaceutical compositions containing the same |
| 01/05/1999 | US5856358 Prevent bone erosion |
| 01/05/1999 | US5856357 Method for treating wrinkles using certain alpha hydroxyacids |
| 01/05/1999 | US5856356 Use of strontium salts and pharmaceutical compositions thereof for the treatment of arthrosis |
| 01/05/1999 | US5856355 Pharmaceutical composition |
| 01/05/1999 | US5856354 Tachykinin antagonists |
| 01/05/1999 | US5856353 Sulfonamide inhibitors of aspartyl protease |
| 01/05/1999 | US5856352 Abruquinone derivatives useful in the treatment of inflammation and allergic reactions |
| 01/05/1999 | US5856350 Psychological disorders |
| 01/05/1999 | US5856349 2-Saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof |
| 01/05/1999 | US5856348 Parasiticides |
| 01/05/1999 | US5856346 Short-acting dihydropyridines |
| 01/05/1999 | US5856345 Method for stabilizing pranoprofen and stable liquid preparation of pranoprofen |
| 01/05/1999 | US5856344 Sulfonylamino-substituted benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic aid, and medicament containing them |
| 01/05/1999 | US5856342 Combination of a β-receptor blocker and a local anaesthetic |
| 01/05/1999 | US5856341 Benzo B! indeno 2,1-D! thiophene compounds, intermediates, processes, compositions and methods |
| 01/05/1999 | US5856340 2-phenyl-3-/alkoxyphenoxy or phenylthio/benzothiophenes |
| 01/05/1999 | US5856339 Post-menopausal syndrome, and uterine fibroid disease, endometriosis, and aortal smooth muscle cell proliferation. |
| 01/05/1999 | US5856338 Sulfonamide-substituted compounds, processes for their preparation, their use as a medicament or diagnostic, and pharmaceutical preparation comprising them |
| 01/05/1999 | US5856336 Anticholesterol agents |
| 01/05/1999 | US5856335 Substituted aminothienopyridines, pharmaceutical composition and use |
| 01/05/1999 | US5856333 Substituted camptothecin derivatives and process for their preparation |
| 01/05/1999 | US5856332 Composition and method of treating depression using a pentacyclic nucleus opioid antagonist in combination with a tricyclic antidepressant |
| 01/05/1999 | US5856331 Method for preventing tissue injury from hypoxia |
| 01/05/1999 | US5856330 Use of xanthine derivatives for the inhibition of dephosphorylation of cofilin |
| 01/05/1999 | US5856329 Method of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injury |
| 01/05/1999 | US5856328 Circulatory disorder improving agent |
| 01/05/1999 | US5856325 Reducing inflammation by inhibiting pla2 in a mammal |
| 01/05/1999 | US5856324 Use of dioxomorpholines for combat endoparasites, dioxomorpholines and process for their production |
| 01/05/1999 | US5856323 Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase |
| 01/05/1999 | US5856321 Preparation of carbapenems |
| 01/05/1999 | US5856320 Antibiotic resistant stapylococcus |
| 01/05/1999 | US5856317 Methods of treatment |
| 01/05/1999 | US5856316 Mixture of higher primary aliphatic alcohols, its obtention from sugar cane wax and its pharmaceutical uses |
| 01/05/1999 | US5856315 Methods for inhibiting proliferation of tumor cells and tumor growth |
| 01/05/1999 | US5856314 Thio-substituted, Nitrogen-containing, heterocyclic phosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism |
| 01/05/1999 | US5856149 Combining a lactobacillus microorganism with cis-9,12 nonconjugated free fatty acids in a fermentation process to form conjugated cis-9 trans-11 linoleic acid. |
| 01/05/1999 | US5856133 G-beta-gamma regulated phosphatidylinositol-3'kinase |
| 01/05/1999 | US5856132 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 01/05/1999 | US5856124 DNA encoding high-affinity melatonin receptors |
| 01/05/1999 | US5856121 Nucleotide sequence |
| 01/05/1999 | US5856115 Screening for enzyme inhibitors |
| 01/05/1999 | US5856098 Detection of this receptor variant in cells of obese individuals, and methods for treating obesity by targeting variant. |
| 01/05/1999 | US5855920 Total hormone replacement therapy |
| 01/05/1999 | US5855918 Cystic fibrosis therapy |
| 01/05/1999 | US5855917 Method for controlling body fat and/or body weight in animals and pharmaceutical compositions for use therein comprising 20-carbon conjugated unsaturated fatty acids |
| 01/05/1999 | US5855915 Tablets or biologically acceptable implants for long-term antiinflammatory drug release |
| 01/05/1999 | US5855913 Particles incorporating surfactants for pulmonary drug delivery |
| 01/05/1999 | US5855912 Pharmaceutical compositions for piperidinalkanol compounds |
| 01/05/1999 | US5855911 Liposomal phosphodiester, phosphorothioate, and P-ethoxy oligonucleotides |
| 01/05/1999 | US5855907 Method of treatment of migraine |
| 01/05/1999 | US5855906 Uniform rate for three weeks |
| 01/05/1999 | US5855905 Androgens or estrogens |
| 01/05/1999 | US5855900 Supramolecular-structured biodegradable polymeric assembly for drug delivery |
| 01/05/1999 | US5855897 Pure cafestol compound |
| 01/05/1999 | US5855892 Administering daidzein |
| 01/05/1999 | US5855873 Storage stability; mouthwashes |
| 01/05/1999 | CA2235103A1 New exocellular polysaccharide produced by streptococcus thermophilus |
| 01/05/1999 | CA2176012C Novel phenylalkylaminoalcohol carbamates and process for preparing the same |
| 01/05/1999 | CA2175091C Controlled release naproxen tablets |
| 01/05/1999 | CA2164286C Indole derivatives in the treatment of emesis |
| 01/05/1999 | CA2157117C Spirocyclic piperidine derivatives |
| 01/05/1999 | CA2152919C Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides |
| 01/05/1999 | CA2152062C Enhanced solubility pharmaceutical solutions |
| 01/05/1999 | CA2132017C Imidazolin derivatives and a method for producing the same and a therapeutic agent for maintaining blood pressure |
| 01/05/1999 | CA2115381C Rifaximin and pharmaceutical compositions containing it in the treatment of gastric dyspepsia caused by helicobacter pylori |
| 01/05/1999 | CA2105541C Programmed release tablets containing naproxen |
| 01/05/1999 | CA2104531C Antimicrobial agent |
| 01/05/1999 | CA2046956C O-methyl derivatives of azithromycin a, process and intermediate for their preparation, and use thereof in the preparation of pharmaceuticals |
| 01/05/1999 | CA2044269C Cafeic acid based pharmaceutical and cosmetic depigmenting compositions |
| 01/05/1999 | CA2043366C Dry eye treatment process and solution |
| 01/05/1999 | CA2005880C Macrocyclic aminophosphonic acid complexes, their preparation formulations and use |
| 01/03/1999 | CA2241879A1 Use of inhibitors of phosphodiesterase 4 for treating allergic rhinitis |
| 01/03/1999 | CA2236462A1 Murc |
| 01/02/1999 | CA2221861A1 Ynl075w/htxft19 |
| 01/01/1999 | CA2242034A1 Cellulose ester wound dressing |
| 01/01/1999 | CA2236459A1 Novel compounds |
| 01/01/1999 | CA2236452A1 Gida1 |
| 01/01/1999 | CA2236441A1 Gida2 |
| 01/01/1999 | CA2236435A1 Gida2 |
| 01/01/1999 | CA2236425A1 Gida1 |
| 01/01/1999 | CA2235785A1 Serine/threonine protein kinase (h-sgk2) |
| 12/30/1998 | WO1998059064A1 Complexes for transporting nucleic acid into eukaryotic higher-cells |
| 12/30/1998 | WO1998059063A2 Bovine adenovirus type 3 genome |
| 12/30/1998 | WO1998059040A2 Human catalytic telomerase sub-unit and its diagnostic and therapeutic use |
| 12/30/1998 | WO1998058965A2 B7-binding molecules for treating immune diseases |
| 12/30/1998 | WO1998058948A1 Tartrate salt of a substituted dipeptide as growth hormone secretagogue |
| 12/30/1998 | WO1998058947A1 Dipeptide derivatives as growth hormone secretagogues |
| 12/30/1998 | WO1998058946A1 Triterpene derivatives and medicinal composition |
| 12/30/1998 | WO1998058944A1 Compositions and methods for activating genes of interest |
| 12/30/1998 | WO1998058939A1 Neurologically-active compounds |
| 12/30/1998 | WO1998058938A1 Alkyl-4-silylheterocyclic phenols and thiophenols as antioxidant agents |
| 12/30/1998 | WO1998058937A1 2,6-DI-t-BUTYL-4-[ (DIMETHYL-4-METHOXYPHENYLSILYL) -METHYLOXY]PHENOL AND 2,6-DI-t-BUTYL-4-[ (DIMETHYL-2-METHOXY-PHENYLSILYL) -METHYLOXY]PHENOL |
| 12/30/1998 | WO1998058934A1 Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and compositions containing same |
| 12/30/1998 | WO1998058933A1 Cephalosporin compounds, use thereof and intermediate compounds of the same |
| 12/30/1998 | WO1998058932A1 Process for the selective preparation of z-isomers of 3-(2-substituted vinyl)cephalosporins |
| 12/30/1998 | WO1998058931A1 PROCESS FOR PRODUCING β-LACTAM DERIVATIVES |
| 12/30/1998 | WO1998058928A1 Prophylactic or therapeutic agent for diseases attributable to infection with helicobacters |
| 12/30/1998 | WO1998058927A1 Soluble prodrugs of paclitaxel |